Abbott Laboratories (NYSE:ABT)

125.60
Delayed Data
As of Nov 26
 +0.53 / +0.42%
Today’s Change
105.32
Today|||52-Week Range
131.60
+14.71%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line4.4B1.4B477.0M2.4B
 
 
 
 
 
Depreciation1.5B1.4B3.0B3.3B
 
 
 
 
 
Total Other Cash Flow-2.8B2.0B1.3B802.0M
 
 
 
 
 
Funds From Operations3.1B4.7B4.8B6.4B
 
 
 
 
 
Extraordinary Items0.00-25.0M-1.2B0.00
 
 
 
Funds From/For Other Operating Expenses156.0M1.5B-1.9B148.0M
 
 
 
 
 
Net Cash Flow - Operating Activities3.0B3.2B5.6B6.3B
 
 
 
 
 
 
InvestingIncrease In Investments-4.9B-2.8B-210.0M-131.0M
 
 
 
 
 
Decrease In Investments6.4B3.7B2.8B73.0M
 
 
 
 
 
Capital Expenditures-1.1B-1.1B-1.1B-1.4B
 
 
 
 
 
Fixed Asset Disposal230.0M25.0M6.0B48.0M
 
 
 
 
 
Net Assets From Acquisitions -235.0M-80.0M-17.2B0.00
 
 
 
 
Other Investing - Sources52.0M42.0M35.0M48.0M
 
 
 
 
 
Net Cash Flow Investing406.0M-248.0M-9.6B-1.4B
 
 
 
 
 
 
FinancingShort Term Borrowings-1.3B-1.8B-1.0B-26.0M
 
 
 
 
 
Long Term Borrowings2.5B14.9B6.7B4.0B
 
 
 
 
 
Long Term Debt Reduction-57.0M-12.0M-8.7B-12.4B
 
 
 
 
 
Net Proceeds Stock Sale314.0M248.0M350.0M271.0M
 
 
 
 
 
Common Preferred Redeemed-2.2B-522.0M-827.0M-238.0M
 
 
 
 
 
Common Dividends-1.4B-1.5B-1.8B-2.0B
 
 
 
 
 
Cash Dividends Paid - Total-1.4B-1.5B-1.8B-2.0B
 
 
 
 
 
Other Sources - Financing----0.000.00--
Other Uses - Financing17.0M195.0M13.0M0.00
 
 
 
 
Net Cash Flow - Financing-2.2B11.1B-5.3B-10.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-198.0M-483.0M116.0M-116.0M
 
 
 
 
 
 
Net Change In Cash1.1B14.1B-9.3B-5.4B